UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)

Circulation (New York, N.Y.), 2017-07, Vol.136 (3), p.249-259

2017

Volltextzugriff (PDF)

SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL

Journal of the American College of Cardiology, 2018-06, Vol.71 (22), p.2497-2506

2018

Volltextzugriff (PDF)

Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2‐inhibitors versus other glucose‐lowering agents in real‐world clinical practice: Results from the CVD‐REAL study

Diabetes, obesity & metabolism, 2018-08, Vol.20 (8), p.1983-1987

2018

Volltextzugriff (PDF)

Response by Kosiborod et al to Letters Regarding Article, “Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)”

Circulation (New York, N.Y.), 2018-02, Vol.137 (9), p.989-991

2018

Volltextzugriff (PDF)

Inappropriate Medication Use and Health Outcomes in the Elderly

Journal of the American Geriatrics Society (JAGS), 2004-11, Vol.52 (11), p.1934-1939

2004

Volltextzugriff (PDF)

PCN5 - Population-Based Comparison Of The Risks Of Serious Adverse Events From Intermittent Versus Continuous Androgen Deprivation Therapy In Advanced Prostate Cancer Patients

Value in health, 2016-05, Vol.19 (3), p.A134-A134

2016

Volltextzugriff (PDF)

Population-Based Comparison Of The Risks Of Serious Adverse Events From Intermittent Versus Continuous Androgen Deprivation Therapy In Advanced Prostate Cancer Patients

Value in health, 2016-05, Vol.19 (3), p.A134-A134

2016

Volltextzugriff (PDF)

UT1 ON THE ISSUE OF UTILITY MULTIPLICATION: A REVISIT

Value in health, 2009, Vol.12 (3), p.A4-A4

Fu, AZ

2009

Volltextzugriff (PDF)

Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10

Diabetes care, 2018-06, Vol.41 (6), p.e106-e108

2018

Volltextzugriff (PDF)

Lower 30-day readmission rates with roflumilast treatment among patients hospitalized for chronic obstructive pulmonary disease

International journal of chronic obstructive pulmonary disease, 2015-01, Vol.10 (Issue 1), p.909-915

2015

Volltextzugriff (PDF)

PCV116 HEALTH-RELATED QUALITY OF LIFE OF DIABETES PATIENTS WITH AND WITHOUT MACROVASCULAR COMORBIDITIES IN THE UNITED STATES

Value in health, 2010, Vol.13 (3), p.A171-A172

2010

Volltextzugriff (PDF)

PDB81 TIME TO ADD-ON MEDICATION USE FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) WHO FAILED METFORMIN MONOTHERAPY

Value in health, 2010, Vol.13 (7), p.A299-A299

2010

Volltextzugriff (PDF)

PMC42 METHODOLOGICAL ISSUES WITHTHE ANALYSIS OF PREFERENCE-BASED EQ-5D INDEX SCORE

Value in health, 2008, Vol.11 (3), p.A181-A181

2008

Volltextzugriff (PDF)

DB3 DIRECT AND INDIRECT COSTS ASSOCIATED WITH DIABETES PATIENTS WITH AND WITHOUT MACROVASCULAR COMORBIDITIES IN THE UNITED STATES

Value in health, 2009, Vol.12 (3), p.A11-A11

2009

Volltextzugriff (PDF)

Age effect on fibrinogen and albumin synthesis in humans

American journal of physiology: endocrinology and metabolism, 1998-12, Vol.275 (6), p.E1023-E1030

1998

Volltextzugriff (PDF)

CS3 HEALTH CARE EXPENDITURE AND PATIENT SATISFACTION: COST AND QUALITY FROM HEALTH CARE CONSUMERS' PERSPECTIVE

Value in health, 2007, Vol.10 (3), p.A13-A13

2007

Volltextzugriff (PDF)

Hospitalisation for heart failure and death in new users of SGLT-2 inhibitors in patients with and without cardiovascular disease: the CVDREAL study

DIABETOLOGIA, 2017, Vol.60, p.S41

2017

Volltextzugriff (PDF)

Total events of hospitalisation for heart failure in new users of SGLT-2 inhibitors: real world data from 5 countries and more than 298,000 patients: the CVD-REAL study

DIABETOLOGIA, 2017, Vol.60, p.S41

2017

Volltextzugriff (PDF)

PIH19 ETHNIC/RACIAL DIFFERENCE IN SELF-ASSESSMENT OF HEALTH STATUS IN THE GENERAL US POPULATION

Value in health, 2010, Vol.13 (7), p.A543-A543

2010

Volltextzugriff (PDF)

PCN42 INDIRECT COST ASSOCIATED WITH BREAST CANCER TO US EMPLOYERS

Value in health, 2010, Vol.13 (3), p.A31-A31

2010

Volltextzugriff (PDF)

PCN41 HEALTH CARE COST OF BREAST CANCER: A CLAIMS DATA ANALYSIS

Value in health, 2010, Vol.13 (3), p.A30-A31

2010

Volltextzugriff (PDF)

OR4 UTILITIES SHOULD NOT BE MULTIPLIED: EVIDENCE FROM THE PREFERENCE-BASED SCORES IN THE UNITED STATES

Value in health, 2008, Vol.11 (6), p.A362-A362

2008

Volltextzugriff (PDF)

PCN8 COMORBIDITIES IN PATIENTS WITH METASTATIC COLORECTAL CANCER

Value in health, 2009, Vol.12 (7), p.A257-A257

2009

Volltextzugriff (PDF)

PR3 RACIAL DIFFERENCES IN PREFERENCE-BASED HEALTH-RELATED QUALITY OF LIFE ASSESSMENT

Value in health, 2006-05, Vol.9 (3), p.A5-A6

2006

Volltextzugriff (PDF)

PCV66 COST SAVINGS OF CORONARY CT ANGIOGRAPHY VS. CARDIAC CATHETERIZATION TO EVALUATE PATIENTS WITH AN ABNORMAL OR NONDIAGNOSTIC STRESS TEST

Value in health, 2008, Vol.11 (6), p.A401-A402

2008

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(78)
Tagungsberichte
(5)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(20)
Physics
(20)
Physical Sciences
(19)
Internal Medicine
(13)
Materials Science
(13)
Physics, Applied
(13)
Engineering
(12)
Technology
(11)
Male
(10)
Engineering, Electrical & Electronic
(9)
Female
(9)
Humans
(9)
Science & Technology - Other Topics
(9)
Medicin Och Hälsovetenskap
(8)
Biological And Medical Sciences
(7)
Chemistry
(6)
Gallium Nitrides
(6)
Nanoscience & Nanotechnology
(6)
Aged
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)

SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL

Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2‐inhibitors versus other glucose‐lowering agents in real‐world clinical practice: Results from the CVD‐REAL study

Inappropriate Medication Use and Health Outcomes in the Elderly

PCN5 - Population-Based Comparison Of The Risks Of Serious Adverse Events From Intermittent Versus Continuous Androgen Deprivation Therapy In Advanced Prostate Cancer Patients

Population-Based Comparison Of The Risks Of Serious Adverse Events From Intermittent Versus Continuous Androgen Deprivation Therapy In Advanced Prostate Cancer Patients

UT1 ON THE ISSUE OF UTILITY MULTIPLICATION: A REVISIT

Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10

Lower 30-day readmission rates with roflumilast treatment among patients hospitalized for chronic obstructive pulmonary disease

PCV116 HEALTH-RELATED QUALITY OF LIFE OF DIABETES PATIENTS WITH AND WITHOUT MACROVASCULAR COMORBIDITIES IN THE UNITED STATES

PDB81 TIME TO ADD-ON MEDICATION USE FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) WHO FAILED METFORMIN MONOTHERAPY

PMC42 METHODOLOGICAL ISSUES WITHTHE ANALYSIS OF PREFERENCE-BASED EQ-5D INDEX SCORE

DB3 DIRECT AND INDIRECT COSTS ASSOCIATED WITH DIABETES PATIENTS WITH AND WITHOUT MACROVASCULAR COMORBIDITIES IN THE UNITED STATES

Age effect on fibrinogen and albumin synthesis in humans

CS3 HEALTH CARE EXPENDITURE AND PATIENT SATISFACTION: COST AND QUALITY FROM HEALTH CARE CONSUMERS' PERSPECTIVE

Hospitalisation for heart failure and death in new users of SGLT-2 inhibitors in patients with and without cardiovascular disease: the CVDREAL study

Total events of hospitalisation for heart failure in new users of SGLT-2 inhibitors: real world data from 5 countries and more than 298,000 patients: the CVD-REAL study

PIH19 ETHNIC/RACIAL DIFFERENCE IN SELF-ASSESSMENT OF HEALTH STATUS IN THE GENERAL US POPULATION

PCN42 INDIRECT COST ASSOCIATED WITH BREAST CANCER TO US EMPLOYERS

PCN41 HEALTH CARE COST OF BREAST CANCER: A CLAIMS DATA ANALYSIS

OR4 UTILITIES SHOULD NOT BE MULTIPLIED: EVIDENCE FROM THE PREFERENCE-BASED SCORES IN THE UNITED STATES

PCN8 COMORBIDITIES IN PATIENTS WITH METASTATIC COLORECTAL CANCER

PR3 RACIAL DIFFERENCES IN PREFERENCE-BASED HEALTH-RELATED QUALITY OF LIFE ASSESSMENT

PCV66 COST SAVINGS OF CORONARY CT ANGIOGRAPHY VS. CARDIAC CATHETERIZATION TO EVALUATE PATIENTS WITH AN ABNORMAL OR NONDIAGNOSTIC STRESS TEST

Suchergebnisse filtern